Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs
Caiyun Yang; Fengxiang Lv; Jiaqi Yang; Dawei Ding; Lina Cui; Ying Han;
10.1016/j.aohep.2024.101582
Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver
Cristiane A. Villela-Nogueira; Maria Lúcia Gomes Ferraz; Mário Guimarães Pessoa; Francisco José Dutra Souto; Letícia Cancella Nabuco; Henrique Sérgio Moraes Coelho; Ezequiel Ridruejo; Marcelo Silva; Paulo Lisboa Bittencourt; Carlos Eduardo Brandão-Mello;
Ann Hepatol. 2023;28:
Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico
JC Jiménez-Mendoza; FE Rivera-López; MF González-Lara; RD Valdez-Echeverría; GE Castro-Narro; A Tore; LF Uscanga-Domínguez; C Moctezuma-Velázquez;
10.1016/j.aohep.2022.100684